Clinical trial
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for…
NCT00264420 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00264420 |
|---|---|
| Title | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation |
| Official title | A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bone Metastases, Breast Cancer, Lung Cancer, Prostate Cancer |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 4 |
| Start date | Dec 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Dec 12, 2005 |
| Last update posted | Dec 21, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: